A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could offer a novel treatment pathway for multiple sclerosis (MS).
Common virus jab could be key in fight against multiple sclerosis … from the Independent Jane Kirby
